ESG |
Material Issues |
Company-wide Action Plan |
KPIs |
SDGs |
E |
Environmental protection
and continuous reduction
of environmental impact |
Environmental protection, continuous
reduction of environmental impact,
and promotion of environmental
management |
1. Reduction of CO2 emissions: Reduction of 46% from FY2013 (FY2030)
2. Reduction of total waste
3. Improvement in recycling rates
4. Promotion of environmental measures
5. Environmentally conscious business operations
6. Reduction of the use of natural resources
7. Reduction of emissions of environmentally harmful substances (reduction of the impact
of nitrogen on the environment by promoting low-protein feed) |
|
S |
Human resource development |
Development of human resources to realize growth strategies |
1. Number of in-house recruitment system and interdepartmental transfers
(number of
career challenges)
2. Number of elective training courses taken: Next-generation leader training
Number of selective training courses taken: Training to promote the advancement of
women (career development of female employees)/other selective training as a measure to
support the autonomous learning of employees
Expenditures per employee (for education)
3. Promote the implementation of internal and external hierarchical training/selective training (career development of female employees) |
|
Employee engagement |
Creation of an environment that
promotes understanding of the
organization, sympathy, and motivation to take action, and
achievement of work-life balance
that respects the health and diversity
of our employees |
1. Optimization of working hours: Promotion of the use of annual paid leave as planned, guidance
for promotion of the use of annual leave, provision of annual leave (taken hourly), etc.
2. Health management initiatives
3. Promotion of various working styles: telecommunicating, telework, flextime, short-time
work, etc.
4. Implementation of regular stress checks and surveys for engagement
5. Promotion of women’s advancement in active roles (FY2024 target): Percentage of female managers (15%)
Percentage of female medical representatives (20%)
6. Promotion of active roles for diverse human resources
7. Measures to support development of the next generation: Maternity leave
(utilization rate 100%) / Childcare leave for male employees (utilization rate 100%)
8. Support for medical representatives to take maternity leave and childcare leave (implementation of reintegration programs, social gatherings, etc.) |
|
Creation of innovative products |
Expansion of pipeline through open innovation |
1. Promotion of in-house research themes
2. Reinforcement of alliance activities
|
|
Expanding access to healthcare |
Contributions to specialty areas by
taking advantage of our own strengths |
1. Provision of comprehensive information on specialty areas (Ob/Gyn, thyroid)
2. Promotion of accurate information and raising disease awareness
3. Early identification of diseases through activities to promote testing and diagnostics
4. Early detection of disease through non-invasive measurement kit |
|
Contribution to women’s health |
Total support for women’s health |
1. Contribution to women’s healthcare by providing products for each of women’s life stages
2. New initiatives for women’s healthcare
3. Promotion of the advancement of women through activities to raise awareness on
health and diseases
4. Sexual education initiatives for younger generation
5. Activities to raise awareness among families and partners about women’s health issues |
|
Contribution to animal health |
Contribution to creation of a society where people and animals can coexist |
1. Promotion of animal welfare
2. Development and provision of products useful for maintaining the health of companion animals
3. Development and provision of non-invasive measurement kit products using body hair
4. Promotion of biodiversity
|
|
Stable supply of
high-quality products
|
Ensuring product quality and stable
procurement and supply
|
1. Reinforcement of supply chain management
2. Implementation of appropriate GMP audits
3. Implementation of appropriate GQP (ensuring that a quality assurance system is in place)
|
|
Promotion of proper use of products |
Ensuring safety and providing
information on proper use |
1. Implementation of appropriate clinical trials (GCP compliance)
2. Adequate implementation of GVP and RMP
3. Compliance with GVP and guidelines for activities for provision of sales information
4. Dissemination of materials and knowledge to promote proper use, and strengthening
product education for medical representatives, etc.
5. Prompt provision of latest information through website
|
|
G |
Corporate governance |
Establishment of corporate system for continuous growth |
1. Fostering corporate culture and climate that respect healthy business ethics
2. Ensuring real equality of shareholders
3. Social contribution activities that lead to solving social issues
4. Constructive dialogue with stakeholders
5. Appropriate disclosure and explanation of management strategy, performance, financial
condition, capital policy, etc. |
|
Secure compliance with laws and regulations, enforcement of compliance |
Thorough maintenance of compliance
and fostering an organizational climate
that emphasizes reliability |
1. Compliance system mainly promoted by Group Compliance Promotion Committee
2. Continuous implementation of preventive measures against serious incidents |
|